This site is intended for healthcare professionals

Adamis Pharmaceuticals provides an update on ZIMHI, high-dose naloxone injection product intended for the treatment of opioid overdose.

Read time: 1 mins
Last updated:13th Apr 2021
Published:13th Apr 2021
Condition: Opioid Dependence/Overdose
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest